FDA initiative may crack wall of secrecy (subscription)

By Charlotte Schubert

Much of the information gathered by the US Food and Drug Administration (FDA) from pharmaceutical companies is ultimately not published. But this data can provide insight into drug efficacy and safety, and thus many people have called for greater access to it. (Click here to continue reading)

Leave a Reply

Your email address will not be published. Required fields are marked *